Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John de Groot

Showing results (1-10 of 87) with videos related to

Pageof 9
Sort By:
Experimental Neurology|September 20, 2017
Rapid identification and validation of novel targeted approaches for Glioblastoma: A combined ex vivo-in vivo pharmaco-omic modelAhmad Daher, John de Groot
Journal of Neuro-Oncology|May 14, 2009
Improving the prognosis for patients with glioblastoma: the rationale for targeting SrcJohn de Groot, Vanessa Milano
Expert Review of Anticancer Therapy|November 6, 2008
Combination therapy for malignant glioma based on PTEN statusJavier Gonzalez, John de Groot
Glia|December 31, 2010
Glutamate and the biology of gliomasJohn de Groot, Harald Sontheimer
Expert Opinion on Pharmacotherapy|July 3, 2019
Challenges and strategies for successful clinical development of immune checkpoint inhibitors in glioblastomaNazanin Majd, John de Groot
Current Opinion in Neurology|September 11, 2024
Updates for newly diagnosed and recurrent glioblastoma: a review of recent clinical trialsCorinna M Fukushima, John de Groot
Current Neurology and Neuroscience Reports|March 22, 2014
Resistance to antiangiogenic therapyShiao-Pei Weathers, John de Groot
Oncology (Williston Park, N.Y.)|October 17, 2015
VEGF Manipulation in GlioblastomaShiao-Pei Weathers, John de Groot
Neuro-Oncology|October 30, 2008
AMPA receptors promote perivascular glioma invasion via beta1 integrin-dependent adhesion to the extracellular matrixYuji Piao, Li Lu, John de Groot
Advances in Experimental Medicine and Biology|April 18, 2020
Immunotherapy for Neuro-OncologyNazanin Majd, Pushan Dasgupta, John de Groot
Pageof 9

Showing results (1-10 of 87) with videos related to

Sort By:
Pageof 9
Experimental Neurology|September 20, 2017
Rapid identification and validation of novel targeted approaches for Glioblastoma: A combined ex vivo-in vivo pharmaco-omic modelAhmad Daher, John de Groot
Journal of Neuro-Oncology|May 14, 2009
Improving the prognosis for patients with glioblastoma: the rationale for targeting SrcJohn de Groot, Vanessa Milano
Expert Review of Anticancer Therapy|November 6, 2008
Combination therapy for malignant glioma based on PTEN statusJavier Gonzalez, John de Groot
Glia|December 31, 2010
Glutamate and the biology of gliomasJohn de Groot, Harald Sontheimer
Expert Opinion on Pharmacotherapy|July 3, 2019
Challenges and strategies for successful clinical development of immune checkpoint inhibitors in glioblastomaNazanin Majd, John de Groot
Current Opinion in Neurology|September 11, 2024
Updates for newly diagnosed and recurrent glioblastoma: a review of recent clinical trialsCorinna M Fukushima, John de Groot
Current Neurology and Neuroscience Reports|March 22, 2014
Resistance to antiangiogenic therapyShiao-Pei Weathers, John de Groot
Oncology (Williston Park, N.Y.)|October 17, 2015
VEGF Manipulation in GlioblastomaShiao-Pei Weathers, John de Groot
Neuro-Oncology|October 30, 2008
AMPA receptors promote perivascular glioma invasion via beta1 integrin-dependent adhesion to the extracellular matrixYuji Piao, Li Lu, John de Groot
Advances in Experimental Medicine and Biology|April 18, 2020
Immunotherapy for Neuro-OncologyNazanin Majd, Pushan Dasgupta, John de Groot
Pageof 9